ATS Announces 2024 Respiratory Health Award Recipients
Awardees will be formally recognized for their contributions to the field at the ATS 2024 International Conference.
Awardees will be formally recognized for their contributions to the field at the ATS 2024 International Conference.
The decree mandates a recall remediation plan and production restrictions to address safety concerns following the widespread 2021 recall of CPAP and BiPAP machines.
Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of Duchenne Muscular Dystrophy.
Jack D. Buckley, MD, MPH, FCCP, has taken office as the 86th president of the American College of Chest Physicians (Chest).
The Centers for Medicare and Medicaid Services (CMS) has assigned a new, unique HCPCs code (E0468) exclusively to the React Health V+C Ventilator with Integrated Cough Assist Technology, according to a company announcement.
The FDA approved osimertinib (Tagrisso) with platinum-based chemotherapy for certain patients with non-small cell lung cancer (NSCLC).
The company recently recalled EVair and Jun-air ventilator accessories due to elevated formaldehyde levels when used with certain ventilators.